Send feedback

EFEMP2 p.Arg53Gln

c.158G>A · rs372018326 · VCV1056034

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.0983 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00411%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
3
Cardiovascular phenotype

Computational evidence

Protein change
AlphaMissense0.0983likely benign
REVEL0.311indeterminate
SaProtLLR -6.00tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.8GERP -0.63, phastCons 1
Regional constrainto/e 0.83unconstrained · MANE · 5,433 bp · p 3.8e-05 · regional, not allelic
Overall
CADD25.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00411% African / African-American · 3/73,010 alleles
Filtering AF 0.00158% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00134%
Overall 0.00206% 32/1,551,494 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00698% 14,327
African / African-Americangrpmax 0.00411% 24,337
European (non-Finnish) 0.00227% 44,114
Remaining individualsnot grpmax-eligible 0.00166% 60,098

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EFEMP2
Protein
p.Arg53Gln
Coding
c.158G>A
MANE Select
NM_016938
dbSNP
rs372018326
Type
single nucleotide variant
Location
chr11:65871972 (GRCh38)
Gene constraint
LOEUF 0.56 · pLI 0.62 (gnomAD)
Structure
AlphaFold pLDDT 82.95 · 1 PDB
Residue 53
the egf-like 1; atypical domain
Full EFEMP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/efemp2-p-arg53gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown